H
Showing 1 - 25 of >10,000
Frequency of h.Pylori in Children With Dyspeptic Symptoms
Not yet recruiting
- H.Pylori Infection
- (no location specified)
Jul 17, 2023
Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)
Not yet recruiting
- Glaucoma Open-Angle Primary
- Ocular Hypertension
- H-1337 0.6%
- +3 more
-
Albany, GeorgiaDixon Eye Care
Jun 12, 2023
Renal Failure, Renal Insufficiency, Renal Disease Trial (H-Guard)
Not yet recruiting
- Renal Failure
- +2 more
- H-Guard
- (no location specified)
Oct 4, 2023
Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)
Active, not recruiting
- Bioequivalence
- Rivastigmine twice-weekly 9,5 mg/24 h
- Exelon® 9.5 mg/24 h
-
Erfurt, Thuringia, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023
Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)
Recruiting
- Bioequivalence
- RID-TDS 13.3 mg/24 h
- Exelon® 13.3 mg/24 h
-
Erfurt, Thüringen, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023
Smoking Cessation Trial (Smiling instead of Smoking - HIV, QuitGuide)
Not yet recruiting
- Smoking Cessation
- Smiling instead of Smoking - HIV
- QuitGuide
- (no location specified)
May 23, 2023
Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies, Hereditary Diseases Trial in Nanning (RM-004)
Recruiting
- Alpha Thalassemia Hemoglobin H Constant Spring
- +2 more
- RM-004
-
Nanning, Guangxi, ChinaThe 923rd Hospital of Joint Logistics Support Force of People's
Oct 25, 2023
Prevalence of H.Pylori in CKD Patients
Not yet recruiting
- H.Pylori Infection
- kidney function tests
- (no location specified)
May 27, 2023
MSI-H Colorectal Cancer Trial in Pittsburgh (Regorafenib, Pembrolizumab)
Not yet recruiting
- MSI-H Colorectal Cancer
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Aug 17, 2023
Non-ischemic Dilated Cardiomyopathy Trial in Spain (Control Strategy, Personalized precision ICD implantation Strategy based in
Not yet recruiting
- Non-ischemic Dilated Cardiomyopathy
- Control Strategy
- Personalized precision ICD implantation Strategy based in genetic findings and CMR results
-
Santiago De Compostela, A Coruña, Spain
- +26 more
Sep 20, 2023
DeepView Snapshot Handheld (DV-H) Comparison Study
Recruiting
- Burns
- Burn
-
New Orleans, LouisianaLSU Health New Orleans University Medical Center New Orleans
Aug 31, 2023
Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab
Not yet recruiting
- Colorectal Cancer
- +3 more
- Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
-
ZhengZhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023
Platelet-Rich Fibrin Trial in Sarajevo (H-PRF (Horizontal-platelet rich fibrin), E-PRF)
Recruiting
- Platelet-Rich Fibrin
- H-PRF (Horizontal-platelet rich fibrin)
- E-PRF
-
Sarajevo, Federation Of Bosnia And Herzegovina, Bosnia and HerzegovinaFaculty of Dentistry with Dental Clinical Center
Mar 14, 2023
Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant
Not yet recruiting
- Multiple Cancer
- Colorectal Cancer
- MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
- All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
- (no location specified)
Aug 20, 2023
Sedentary Behaviour, Sedentary Time Trial in Kastamonu (Aerobic exercise+6.5 h of prolonged sitting, Aerobic exercise+2 minutes
Active, not recruiting
- Sedentary Behaviour
- Sedentary Time
- Aerobic exercise+6.5 h of prolonged sitting
- +3 more
-
Kastamonu, TurkeyKastamonu University, Çatalzeytin Vocational School
Oct 27, 2023
MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)
Not yet recruiting
- MSI-H Colorectal Cancer
- +3 more
- (no location specified)
Apr 23, 2023
Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H
Recruiting
- Colorectal Cancer
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 18, 2023
DNA Methylation and Histone Modification in H. Pylori Associated
Recruiting
- Gastric Carcinoma
- Immunohistochemical staining for DNMT1 and EZH2
-
Assiut, EgyptAssiut University
Mar 31, 2023
MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)
Not yet recruiting
- MSI-H/dMMR Gastroesophageal-junction Cancer
- MSI-H/dMMR Gastric Cancer
- S095029
- Pembrolizumab 200 mg
- (no location specified)
Oct 30, 2023
Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)
Not yet recruiting
- Healthy
- H107e
- +10 more
-
Pretoria, Gauteng, South AfricaAurum Institute
Sep 24, 2023
Alzheimer, H Pylori Infection Trial in Taichung city (Black raspberry, Placebo)
Completed
- Alzheimer Disease
- H Pylori Infection
- Black raspberry
- Placebo
-
Taichung city, Taichung, TaiwanChung Shan Medical University
Dec 23, 2022
Gastritis H Pylori Trial (Endoscopy)
Not yet recruiting
- Gastritis H Pylori
- Endoscopy
- (no location specified)
Aug 23, 2023
Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (PD-1 inhibitor)
Recruiting
- Gastric or Gastroesophageal Junction Adenocarcinoma
- PD-1 inhibitor
-
Guangzhou, ChinaSun Yat-sen University Cancer Center
Aug 9, 2023
Bone Injury Trial (induced membrane technique, Bone graft (Stage II of IMT))
Not yet recruiting
- Bone Injury
- induced membrane technique
- Bone graft (Stage II of IMT)
- (no location specified)
Mar 30, 2023